Source link : https://www.newshealth.biz/health-news/experts-debate-whether-ira-provisions-stifle-pharma-innovation-at-senate-hearing/
WASHINGTON — The Inflation Reduction Act (IRA) provisions aimed at lowering prescription drug prices will lead to more pharmaceutical innovation, not less, one witness said at a Senate Finance Committee hearing. “These reforms support innovation in a number of ways — first, by expanding the use of drugs, greater profits in the industry should follow,” […]
Author : News Health
Publish date : 2024-09-18 21:05:22
Copyright for syndicated content belongs to the linked Source.